Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Amortization of Deferred Charges: 2013-2024

Historic Amortization of Deferred Charges for Rockwell Medical (RMTI) over the last 8 years, with Dec 2024 value amounting to $426,000.

  • Rockwell Medical's Amortization of Deferred Charges rose 1.14% to $89,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $354,000, marking a year-over-year decrease of 69.69%. This contributed to the annual value of $426,000 for FY2024, which is 61.52% down from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Amortization of Deferred Charges is $426,000, which was down 61.52% from $1.1 million recorded in FY2023.
  • Rockwell Medical's 5-year Amortization of Deferred Charges high stood at $1.1 million for FY2023, and its period low was $294,000 during FY2020.
  • In the last 3 years, Rockwell Medical's Amortization of Deferred Charges had a median value of $426,000 in 2024 and averaged $634,000.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first surged by 200.00% in 2023, then tumbled by 61.52% in 2024.
  • Over the past 5 years, Rockwell Medical's Amortization of Deferred Charges (Yearly) stood at $294,000 in 2020, then grew by 25.51% to $369,000 in 2021, then remained steady at $369,000 in 2022, then skyrocketed by 200.00% to $1.1 million in 2023, then tumbled by 61.52% to $426,000 in 2024.